JavaScript is disabled for your browser. Some features of this site may not work without it.
Supplementing the immune system with plant-produced antibodies

Author
Hein, Mich B.
Abstract
The forefront of agriculture/medicine interactions is the use of plants to manufacture innovative medicinal products directly. An emerging biopharmaceutical industry geared toward manufacture of human monoclonal antibodies using crop plants as factories, reduces the serious manufacturing bottleneck that often currently prevents mass-scale application of antibody therapeutics from meeting clinical needs. This medical market, already valued at $4 billion a year, could be revolutionized a biotech-based production system.
Date Issued
2002Publisher
NABC
Subject
GMO; human health; genetic engineering; communication; science communication; pharming; regulation, trust;
Rights
Attribution-NonCommercial-NoDerivatives 4.0 International
Type
book chapter
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International